palmitoylethanolamide.com.au
HomeResearchCordaro 2020

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events

Cordaro M, Cuzzocrea S, Crupi R. Antioxidants, 2020; 9(3):216.

ReviewHumansOther animalsWith luteolin

This study tested palmitoylethanolamide together with luteolin. Its results cannot be assigned to palmitoylethanolamide alone. More combination studies.

Design
Review
What was measured
A narrative review of palmitoylethanolamide, alone and co-ultramicronised with luteolin, in inflammation of the nervous system

What the authors reported

The authors describe palmitoylethanolamide as protective and anti-inflammatory in laboratory models, and note that it has no antioxidant activity of its own. They present this as the reason for pairing it with the flavonoid luteolin, and they report that the combination outperformed either compound alone in laboratory work.

Limits of this study

A narrative review that rests mainly on cell and animal studies. The authors note that knowledge of the mechanisms is incomplete and comes mostly from laboratory models. The funding and conflict statements were not visible on the page checked.

Source

doi:10.3390/antiox9030216

Entry checked against the full text at the publisher (MDPI) on 2026-09-21. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.